AI assistant
Sending…
Evogene Ltd. — Earnings Release 2021
May 26, 2021
6785_rns_2021-05-26_69cdb4fe-002c-41df-ac18-ac4bd424af5e.htm
Earnings Release
Open in viewerOpens in your device viewer
_________ false
| ����� ��"� | 2 381 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 13041 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 26/05/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-090720 | Time of broadcast: 15:22 15:22 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | ����� ���� ������� ����� ����� ���� |
PR_Q1_Results_Call_in_Details_isa.pdf
| ���� ���� ������� ������� ����� ������ ���� ���� 16:00 ���� ����� Conference Call & Webcast Details: Date: May 26, 2021 Time: 9:00 am EST; 16:00 Israel time Dial-in number:1-888-281-1167 toll free from the United States, or +972-3-918-0609 internationally Webcast: Available at www.evogene.com | |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| 2021-02-090684 | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 04/05/2021 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: | |
| Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Regulatory Filings
2026
Jun 9
Report Publication Announcement
2026
Jun 9
Report Publication Announcement
2026
Jun 2
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 20
Share Issue/Capital Change
2026
May 20
Earnings Release
2026
May 20
Report Publication Announcement
2026
May 20
Capital/Financing Update
2026
May 20
Regulatory Filings
2026
May 20